Atlas Trials

Study to Evaluate the Safety and Efficacy of Adeno-IFN Gamma in Cutaneous B-cell Lymphoma

Clinical trial NCT00394693 · COMPLETED

Trial details

NCT number
NCT00394693
Sponsor
Transgene
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lymphoma, B-Cell
Start date
2006-11-01
Primary completion
2010-01-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.